Differential diagnosis between @entity788 / @entity6052 / and @entity788 can be very difficult. The main clinical symptoms in @entity1 with @entity788 are @entity1087 , @entity353 , @entity490 and new onset of @entity6 . Unfortunately, the same symptoms could be observed in @entity1 with @entity3123 too. Imaging methods as computed tomography /CT/ scan, magnetic resonance imaging /MRI/ and endosonography /EUS/; together with serological examination /IgG4 and Ca 19--9/ play the important role in differentiation @entity788 from @entity788 . Extrapancreatic findings are distinctive in @entity1 with @entity788 . In some cases the pancreatic biopsy is indicated, mainly in @entity1 with focal or multifocal form of @entity788 . Response to @entity230 /decreased pancreatic or extrapancreatic lesion or damage/ is distinctive to @entity6052 . In clinical practice, CT scan seems to be the most reasonable/ tool for examining the @entity1 with @entity3883 with or without present pancreatic mass/. Stratification the @entity1 with possible @entity6052 versus @entity788 is important. In @entity1 with @entity6052 it may avoid pancreatic resection, as well as incorrect @entity134 treatment in @entity1 with @entity3123 .

Differentiating @entity788 from XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity3123 :: ('MESH:C562463', 'Disease') :: ['pancreatic carcinoma'] @entity788 :: ('MESH:D010190', 'Disease') :: ['autoimmune pancreatitis', 'pancreatic cancer'] @entity3883 :: ('MESH:D041781', 'Disease') :: ['obstructive jaundice /'] @entity1087 :: ('MESH:D007565', 'Disease') :: ['jaundice'] @entity353 :: ('MESH:D015431', 'Disease') :: ['weight loss'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes mellitus'] @entity134 :: ('CHEBI:35341', 'Chemical') :: ['steroid'] @entity6052 :: ('MESH:D017118', 'Disease') :: ['AIP'] @entity490 :: ('MESH:D015746', 'Disease') :: ['abdominal pain'] @entity230 :: ('MESH:D013256', 'Chemical') :: ['steroids']
@entity788 :: (MESH:D010190,Disease) :: ['pancreatic cancer']
